Trials / Completed
CompletedNCT01101230
Effects of Almonds on Cardiovascular Risk Factors
Effects of a Diet Rich in Almonds on LDL Cholesterol, LDL Particle Size, Abdominal Adiposity and Vascular Health
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- Penn State University · Academic / Other
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research is to build the evidence base for approval of FDA health claims related to almonds and cardiovascular disease. A randomized, 2-period, crossover controlled feeding study was designed to compare the effects of two blood cholesterol lowering diets that meet the American Heart Association recommendations. The nutrient profiles of the control diet (no almonds/day) and almond diet (1.5 oz. of almonds/day) are matched for protein, saturated fat, and cholesterol. The study population consists of two cohorts of 25 men and women with moderately elevated LDL-C. The investigators hypothesize that a cholesterol-lowering diet designed with almonds confers greater cardioprotective effects than a cholesterol-lowering diet without almonds on the basis of the LDL-C lowering response, effect on LDL particle size, abdominal adiposity and vascular health.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Almonds | 1.5 oz almonds/day |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2012-05-01
- Completion
- 2012-05-01
- First posted
- 2010-04-09
- Last updated
- 2023-08-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01101230. Inclusion in this directory is not an endorsement.